Thrombocytopenia in Relation to Tumor Size in Patients with Hepatocellular Carcinoma
Thrombocytopenia in Relation to Tumor Size in Patients with Hepatocellular Carcinoma
复制标题
DOI:
10.1159/000342431
复制
发表时间:
2012-01-01
期刊:
影响因子:
3.5
通讯作者:
Pancoska, Petr
中科院分区:
文献类型:
--
作者:
Carr, Brian I.;Guerra, Vito;Pancoska, Petr
Background: Hepatocellular carcinoma (HCC) size at diagnosis is important in management. Without screening programs, tumor size at diagnosis is heterogeneous. Aims: To examine the clinical parameters related to tumor size. Methods: Using prospectively collected data from a 1,100-patient biopsy-proven HCC cohort presenting in the absence of screening, tumor sizes were ordered and trichotomized and the resulting terciles were compared for tumor and blood parameters. Results:The terciles were significantly different with respect to portal hypertension and thrombocytopenia, which were present in a higher percent of tercile I patients with smaller tumors. Tercile III patients with larger HCCs had the highest serum alpha-fetoprotein (AFP), gamma-glutamyl transpeptidase (GGTP), and alkaline phosphatase (ALKP) levels and the most portal vein (PV) thrombosis. Subclassification of tercile I patients by AFP showed that patients with high serum AFP had increased numbers of tumor nodules, more PV thrombosis, higher bilirubin, ALKP, and GGTP levels, and shorter survival. Conclusions: Smaller-tumor tercile I patients had more advanced portal hypertension with thrombocytopenia than did larger-tumor patients. Tercile I patients with higher AFP levels had more frequent PV thrombosis and worse survival than those with lower AFP levels. Elevated serum GGTP and ALKP levels appear to be associated with a more aggressive HCC phenotype. These differing patterns suggest more than one HCC pathway. Copyright (c) 2012 S. Karger AG, Basel